Adheris Study Finds Antidepressant Discontinuation Most Likely At The Start Of Therapy Among Newly Treated And Previously Lapsed Patients
Adheris, Inc., a leader in patient adherence and education programs, announced today the results of a new study that examined adherence rates among patients on SSRI/SNRI antidepressant therapy.
Study results showed that patients new to antidepressant treatment and those who had restarted therapy after a lapse of 6 or more months were twice as likely to [...]